From Congresswoman Lucy McBath <[email protected]>
Subject Insulin is now affordable for millions of Americans
Date January 6, 2024 12:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Learn more about what my office has been up to this week Dear john, It is my hope that your new year is off to a wonderful start. Before heading back to Washington next week, I wanted to share an important update with you regarding my work to make prescription drugs more affordable. The start of 2024 marked the one year anniversary since my plan to cap the cost of insulin at $35 a month for seniors on Medicare went into effect. This was a landmark moment for seniors who depend on insulin to live healthy lives. Thanks to the Inflation Reduction Act and our sustained pressure on drugmakers, every major insulin manufacturer in the nation has since announced price caps and savings programs to dramatically lower the cost of insulin for patients. Effective January 1, 2024, Sanofi was the third and final drugmaker to implement $35 price caps for insulin. This week's news brings needed relief for families who have struggled with the cost of health care for diabetes, and I will continue to champion policies in Congress which will lower prescription drug prices for all Americans. There is no reason why a lifesaving drug that has been around for 100 years should bankrupt American families. Thank you for taking the time to read this update. It is my honor to serve our community in Congress. If you ever have any questions or concerns, please do not hesitate to get in touch with my office. Sincerely, Lucy McBath Member of Congress By participating in or clicking this survey, you will be subscribed to receive e-newsletter updates. Office of Rep. Lucy McBath | 2246 Rayburn House Office Building, Washington, DC 20515 Unsubscribe [email protected] Update Profile | Constant Contact Data Notice Sent by [email protected]
Screenshot of the email generated on import

Message Analysis